Authors
Andrew Wolf, MD, is an assistant professor of neurology at the University of Colorado Anschutz.
Lung cancer patient, advocate, cofounder and president of EGFR Resisters.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
2
5 Ongoing Clinical Trials in Myeloproliferative Neoplasms
3
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology
4
Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV
5
